Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and lessen the severity of illness, according to new research published in Cell.
Current seasonal influenza vaccines mainly target a different, more abundant influenza surface protein called hemagglutinin (HA). However, because influenza vaccines offer varying and sometimes limited protection, scientists are exploring ways to improve vaccine effectiveness. The new research builds on previous studies of NA and was conducted by a team of scientists including investigators from the Centers of Excellence for Influenza Research and Surveillance (CEIRS)program, which is organized and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Investigators analyzed blood samples from people vaccinated against influenza and people diagnosed with either the 2009 H1N1 influenza virus or H3N2 influenza viruses. The volunteers were recruited for this study or had taken part in prior influenza research studies. The analyses indicate that influenza vaccines rarely induce NA-reactive antibodies, whereas natural influenza infection induces these types of antibodies at least as often as they induce HA-reactive antibodies. Additional studies in mice reinforced the human data, indicating that current influenza vaccines do not induce NA-reactive antibodies efficiently.
Additional laboratory experiments show that the NA-reactive antibodies induced during natural influenza infection are broadly reactive, meaning they could potentially protect against diverse strains of influenza. To test this theory, scientists isolated NA-reactive monoclonal antibodies from the H3N2 and H1N1 influenza patients (N2-reactive antibodies and N1-reactive antibodies, respectively). They administered 13 N2-reactive antibodies to mice and subsequently infected the mice with a different H3N2 virus strain. Eleven of the 13 N2-reactive antibodies partially or fully protected the mice. They also administered eight N1-reactive antibodies to mice and subsequently infected the mice with a similar H1N1 virus strain or an H5N1-like virus strain. Four of the eight antibodies completely protected the mice against both virus strains.
The authors note that the findings suggest that influenza vaccines should be optimized to better target NA for broad protection against diverse influenza strains. In this regard, NIAID is supporting research to characterize NA responses in infected and vaccinated individuals and to determine the mechanism of action of NA protection. NIAID also supports “NAction!” a CEIRS working group that identifies knowledge gaps in our understanding of NA and sets NA research priorities for improved influenza vaccines. These efforts contribute to NIAID’s larger plan to develop a universal influenza vaccine—a vaccine that can durably protect all age groups against multiple influenza virus strains.
The Latest on: Influenza
via Google News
The Latest on: Influenza
- Australia’s major cities are increasingly vulnerable to future influenza pandemics on December 17, 2018 at 3:03 am
Our cities are facing a growing vulnerability to pandemics, a University of Sydney research team has found. A large jump in arrivals by air and urbanisation are the two main factors that are making it ... […]
- Traveling Back: Spanish Influenza almost stopped Christmas from coming on December 14, 2018 at 11:52 am
1918 was a hard year, not only for Door County but for the entire world. The war in Europe had been raging for four years, taking the lives of young men as they fought and died on foreign battlefields ... […]
- CDC selects UMass Amherst biostatistician model that helps predict influenza outbreaks on December 12, 2018 at 11:09 pm
When the Centers for Disease Control and Prevention was looking for a preferred flu prediction model for use in its flu-forecasting challenge this season, an influenza-tracking model developed by a te... […]
- Influenza Cataclysm, 1918 on December 12, 2018 at 4:25 pm
This year marks the centennial of an influenza pandemic that killed 50 million to 100 million people globally — arguably the single deadliest event in recorded human history. Evidence suggests that an... […]
- Pet Health: Canine Influenza on December 12, 2018 at 11:56 am
(KUSI) – Canine influenza is very similar to the human flu and Dr. Angela Gaeto from Helen Woodward Animal Center visited Good Morning San Diego to discuss what owners can do to keep your pets from ge... […]
- Urbanization affects peak timing, prevalence, and bimodality of influenza pandemics in Australia: Results of a census-calibrated model on December 12, 2018 at 11:19 am
1 Complex Systems Research Group, School of Civil Engineering, Faculty of Engineering and IT, The University of Sydney, Sydney, NSW 2006, Australia. 2 Marie Bashir Institute for Infectious Diseases an... […]
- 'Influenza' and 'Pandemic 1918' review: Books by Dr. Jeremy Brown and Catharine Arnold document how the flu killed 50-100 million on December 12, 2018 at 4:28 am
INFLUENZA: The Hundred-Year Hunt to Cure the Deadliest Disease in History, by Dr. Jeremy Brown. Touchstone, 258 pp., $26.99. PANDEMIC 1918: Eyewitness Accounts from the Greatest Medical Holocaust in M... […]
- Reindeer influenza plaguing Austin area Elves on the Shelf on December 9, 2018 at 7:37 pm
AUSTIN (KXAN) — Parents, if your Elf on the Shelf is seeming a little under the weather, he or she may have a bad case of reindeer influenza. It's a form of reindeer flu that cannot be contracted by h... […]
- MN Department of Health urges action to limit influenza this winter on December 7, 2018 at 6:40 pm
BEMIDJI -- A year after hundreds of deaths and thousands of hospitalizations because of influenza, health officials are reminding the public to get vaccinated. “The first thing we do is recommend ever... […]
via Bing News